Silicon Laboratories (SLAB) FY2019 results: revenue $474 million, down 45.4% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $474 million for fiscal 2019, the year ended 28 December 2019, down 45.4% on the year before. Net income was $19 million, down 77.0%, and diluted earnings per share $0.43. The figures are the company's own, from the 10-K it filed with the SEC on 29 January 2020.
Revenue
$474 million
-45.4% on the year
FY2012FY2019
Operating margin
-18.7%
9.8% a year earlier
FY2012FY2019
Net income
$19 million
-77.0% on the year
FY2012FY2019
Diluted EPS
$0.43
-77.4% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
474
868
769
-45.4%
Cost of revenue
194
347
315
-44.2%
Gross profit
280
521
454
-46.3%
Gross margin
59.1%
60.1%
59.1%
Research and development
206
238
209
-13.7%
Selling, general and administrative
163
198
160
-17.5%
Operating income
-88.6
85.2
85.0
Operating margin
-18.7%
9.8%
11.1%
Interest expense
20.2
19.7
n/a
+2.7%
Pre-tax income
-96.0
72.2
76.9
Income tax
7.0
-11.4
29.8
Effective tax rate
n/a
-15.8%
38.8%
Net income
19.3
83.6
47.1
-77.0%
Net margin
4.1%
9.6%
6.1%
Diluted EPS
$0.43
$1.90
$1.09
-77.4%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
167
174
190
-4.0%
Capital expenditure
15.3
24.5
12.3
-37.5%
Free cash flow
151
149
177
+1.4%
Free cash flow margin
31.9%
17.2%
23.1%
Cash from investing
-107
-197
-374
Cash from financing
-29.6
-48.8
313
Depreciation and amortisation
52.9
53.9
41.9
-1.8%
Share-based compensation
44.3
50.1
44.8
-11.5%
Buybacks
26.7
39.3
n/a
-32.0%
Diluted shares, weighted
44m
44m
43m
+0.6%
Shares outstanding at period end
43m
43m
43m
+0.9%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
1,115
1,067
953
+4.5%
Debt
368
355
342
+3.8%
Other liabilities
192
202
240
-5.3%
Total liabilities and equity
1,675
1,624
1,535
+3.1%
Fixed assets
136
139
128
-2.2%
Goodwill
237
397
288
-40.3%
Intangible assets
134
171
83.1
-21.4%
Investments
499
417
495
+19.7%
Cash and equivalents
227
197
269
+15.3%
Receivables
75.6
73.2
71.4
+3.3%
Inventory
73.1
75.0
73.1
-2.6%
Other assets
293
155
128
+88.7%
Total assets
1,675
1,624
1,535
+3.1%
10-K for the year ended 28 December 2019, filed 29 January 2020: the filing.